Clasificación en acciones
#16218
Opus Genetics, Inc. is a clinical-stage biopharmaceutical company focused on... Opus Genetics, Inc. is a clinical-stage biopharmaceutical company focused on ophthalmology. The company is dedicated to discovering and commercializing innovative therapies to address significant unmet medical needs in patients suffering from refractive and retinal eye disorders. Its portfolio includes Phentolamine Ophthalmic Solution, currently used to reverse pharmacologically induced mydriasis (pupil dilation). This solution is also advancing through Phase III clinical trials for the treatment of presbyopia and impaired vision in dim light or at night. A leading candidate in its retinal pipeline is APX3330, a small-molecule inhibitor targeting the reduction oxidation effector factor-1 protein. APX3330 has successfully completed Phase II clinical trials for diabetic retinopathy. Furthermore, Opus Genetics is developing APX2009 and APX2014, two preclinical product candidates also aimed at various retinal indications. Originally founded in 2018 as Ocuphire Pharma, Inc., the company maintains its headquarters in Farmington Hills, Michigan.
Precio por acción
$3.70
Última sincronización: 2026-07-31
Capitalización bursátil
$305.87M
Comercio Opus Genetics, Inc. (IRD)
Precio IRD con Capital del mercado a B
Capitalización de mercado de Opus Genetics, Inc.(IRD)
Capitalización bursátil: $305.87M
A fecha de September 2026, Opus Genetics, Inc. tiene una capitalización de mercado de $305.87M. Esto convierte a Opus Genetics, Inc. en la 16218th empresa más valiosa del mundo por capitalización bursátil, según nuestros datos. La capitalización bursátil es el valor total de mercado de las acciones en circulación de una empresa que cotiza en bolsa y se utiliza comúnmente para medir su valor.
Historial de capitalización de mercado de Opus Genetics, Inc. desde 2024 hasta 2026
IRD en comparación con los más populares 5 títulos stocks
| Precio por IRD |
|
Activo B |
Capital del mercado en B |
Resultados |
|
|
|
|
$5.260T
|
+1,719,438.14%
|
|
|
|
|
$4.779T
|
+1,562,157.96%
|
|
|
|
|
$4.017T
|
+1,313,103.81%
|
|
|
|
|
$3.719T
|
+1,215,863.74%
|
|
|
|
|
$2.734T
|
+893,812.25%
|
